trustmebro.to/r/…

✓ checked

trust me, bro:

here is the receipt.

the claim

An imbalance between the production and clearance of amyloid-β peptides plays a critical role in the progression of Alzheimer’s disease.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that an imbalance between the production and clearance of amyloid-β peptides plays a critical role in the progression of Alzheimer’s disease?

Yes. An imbalance between the production and clearance of amyloid-beta peptides is widely supported by recent literature as a critical driver of Alzheimer's disease progression.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked 4 Oct 2026

The analysis

The retrieved papers consistently highlight amyloid-beta accumulation driven by production-clearance imbalances, impaired glymphatic or lysosomal clearance mechanisms, and genetic predispositions such as APOE e4. These findings firmly align with the claim that an imbalance between amyloid production and clearance plays a critical role in Alzheimer's disease.

Evidence for · 7

Sleep-Dependent Clearance of Brain Metabolites via the Glymphatic System: Implications for Alzheimer's Pathophysiology.

2026

This study emphasizes that sleep-dependent glymphatic clearance promotes the removal of amyloid-beta, and its disruption accelerates Alzheimer's disease pathophysiology.

Get citation

F, Z., G, S., J, R., A, S., RS, A., V, P., & M, K. (2026). Sleep-Dependent Clearance of Brain Metabolites via the Glymphatic System: Implications for Alzheimer's Pathophysiology.. doi.org. https://doi.org/10.1002/brb3.71374

See more details

More for · 6

Glycative Stress and the progression of Alzheimer-type Dementia: From the Perspective of Amyloid-beta Clearance

2022

This review highlights that impaired amyloid-beta clearance due to glycative stress and advanced glycation endproducts contributes to Aβ polymerization and Alzheimer-type dementia progression.

Get citation

Yonei, Y., Yagi, M., & Mamun-or-Rashid, A. (2022). Glycative Stress and the progression of Alzheimer-type Dementia: From the Perspective of Amyloid-beta Clearance. doi.org. https://doi.org/10.18103/mra.v10i12.3374

Lipid metabolism, neuroinflammation, and oxidative stress in Alzheimer disease: an integrated mechanistic review.

2026

This paper notes that the APOE e4 allele links lipid dysregulation directly to impaired amyloid clearance in Alzheimer's disease.

Get citation

L, L., Y, T., G, S., Y, L., C, C., C, C., & W, L. (2026). Lipid metabolism, neuroinflammation, and oxidative stress in Alzheimer disease: an integrated mechanistic review.. doi.org. https://doi.org/10.1007/s13760-026-03064-2

Alzheimer's Disease: From Molecular Pathogenesis to Disease-Modifying Therapies and Clinical Implementation in Aging Populations.

2026

This comprehensive review reaffirms that amyloid cascade dysfunction, including peptide imbalance, drives the core molecular pathophysiology of Alzheimer's disease.

Get citation

A, Z., R, A., R, D., A, N., & MM, E. (2026). Alzheimer's Disease: From Molecular Pathogenesis to Disease-Modifying Therapies and Clinical Implementation in Aging Populations.. doi.org. https://doi.org/10.2147/cia.s639690

Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy.

2026

This study underscores that impaired protein clearance and amyloid-beta accumulation represent critical druggable axes driving Alzheimer's disease progression.

Get citation

J, P. (2026). Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy.. doi.org. https://doi.org/10.12779/dnd.2026.25.3.152

Ventricular enlargement is associated with early Alzheimer's disease pathophysiology.

2026

This research demonstrates that cerebrospinal fluid dynamics and ventricular volume abnormalities are closely associated with altered amyloid-beta clearance and early Alzheimer's pathophysiology.

Get citation

SA, H., E, A., N, R., MS, W., AC, M., B, H., L, T., T, C., J, F. A., YT, W., S, S., J, T., Y, Z., KQ, S., G, B., C, T., D, O., R, H., CH, H., C, S., J, S., F, L., L, W., M, C., S, C., V, F., G, M., Y, I., JP, S., DA, R., S, G., T, K., AL, B., NJ, A., H, Z., M, M., P, V., K, B., DL, C., J, K., TA, P., & P, R. (2026). Ventricular enlargement is associated with early Alzheimer's disease pathophysiology.. doi.org. https://doi.org/10.1093/braincomms/fcag066

Genetic factors complicating recovery in patients with brain injury: Possible link between injury severity and posttraumatic neurodegeneration related to intracerebral amyloid deposition - A narrative review.

2026

This review notes that impaired intracerebral amyloid-beta clearance following brain injury promotes posttraumatic neurodegeneration and related pathologies.

Get citation

B, S., M, Z., T, V., & S, F. (2026). Genetic factors complicating recovery in patients with brain injury: Possible link between injury severity and posttraumatic neurodegeneration related to intracerebral amyloid deposition - A narrative review.. doi.org. https://doi.org/10.25259/sni_5_2026

What does the evidence say?

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work